Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 258

1.

The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial.

Huseini HF, Larijani B, Heshmat R, Fakhrzadeh H, Radjabipour B, Toliat T, Raza M.

Phytother Res. 2006 Dec;20(12):1036-9.

PMID:
17072885
[PubMed - indexed for MEDLINE]
2.

The clinical investigation of Citrullus colocynthis (L.) schrad fruit in treatment of Type II diabetic patients: a randomized, double blind, placebo-controlled clinical trial.

Huseini HF, Darvishzadeh F, Heshmat R, Jafariazar Z, Raza M, Larijani B.

Phytother Res. 2009 Aug;23(8):1186-9. doi: 10.1002/ptr.2754.

PMID:
19170143
[PubMed - indexed for MEDLINE]
3.
5.
6.

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. doi: 10.1016/j.clinthera.2008.08.006. Erratum in: Clin Ther. 2008 Oct;30(10):1937.

PMID:
18803987
[PubMed - indexed for MEDLINE]
7.

Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.

Derosa G, Cicero AF, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, Fassi R, Fogari R.

Clin Ther. 2007 Apr;29(4):602-10.

PMID:
17617283
[PubMed - indexed for MEDLINE]
8.

The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies.

Dans AM, Villarruz MV, Jimeno CA, Javelosa MA, Chua J, Bautista R, Velez GG.

J Clin Epidemiol. 2007 Jun;60(6):554-9. Epub 2006 Nov 13.

PMID:
17493509
[PubMed - indexed for MEDLINE]
10.

Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients.

Ziai SA, Larijani B, Akhoondzadeh S, Fakhrzadeh H, Dastpak A, Bandarian F, Rezai A, Badi HN, Emami T.

J Ethnopharmacol. 2005 Nov 14;102(2):202-7. Epub 2005 Sep 8.

PMID:
16154305
[PubMed - indexed for MEDLINE]
11.

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.

Bays HE, Goldberg RB, Truitt KE, Jones MR.

Arch Intern Med. 2008 Oct 13;168(18):1975-83. doi: 10.1001/archinte.168.18.1975.

PMID:
18852398
[PubMed - indexed for MEDLINE]
12.

Safety profile and metabolic effects of 14 days of treatment with DIO-902: results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitus.

Schwartz SL, Rendell M, Ahmann AJ, Thomas A, Arauz-Pacheco CJ, Welles BR.

Clin Ther. 2008 Jun;30(6):1081-8. doi: 10.1016/j.clinthera.2008.05.021.

PMID:
18640464
[PubMed - indexed for MEDLINE]
13.

Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.

Derosa G, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, Cicero AF.

J Clin Pharm Ther. 2009 Feb;34(1):13-23. doi: 10.1111/j.1365-2710.2008.00984.x.

PMID:
19125899
[PubMed - indexed for MEDLINE]
14.

Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.

Gharagozloo M, Moayedi B, Zakerinia M, Hamidi M, Karimi M, Maracy M, Amirghofran Z.

Fundam Clin Pharmacol. 2009 Jun;23(3):359-65. doi: 10.1111/j.1472-8206.2009.00681.x. Epub 2009 May 7.

PMID:
19453758
[PubMed - indexed for MEDLINE]
15.

The effects of polyphenol-containing antioxidants on oxidative stress and lipid peroxidation in Type 2 diabetes mellitus without complications.

Fenercioglu AK, Saler T, Genc E, Sabuncu H, Altuntas Y.

J Endocrinol Invest. 2010 Feb;33(2):118-24. doi: 10.3275/6564. Epub 2009 Oct 15.

PMID:
19834314
[PubMed - indexed for MEDLINE]
16.

Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.

Schwartz SL, Ratner RE, Kim DD, Qu Y, Fechner LL, Lenox SM, Holcombe JH.

Clin Ther. 2008 May;30(5):858-67. doi: 10.1016/j.clinthera.2008.05.004.

PMID:
18555933
[PubMed - indexed for MEDLINE]
17.
19.

Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L. leaf extract: a randomized placebo. Controlled clinical trial.

Kianbakht S, Dabaghian FH.

Complement Ther Med. 2013 Oct;21(5):441-6. doi: 10.1016/j.ctim.2013.07.004. Epub 2013 Aug 6.

PMID:
24050577
[PubMed - indexed for MEDLINE]
20.

Comparative study on the efficacy of pioglitazone in Caucasian and Maori-Polynesian patients with poorly controlled type 2 diabetes.

Shand B, Scott R, Connolly S, Clarke R, Baker J, Elder P, Frampton C, Yeo J.

Diabetes Obes Metab. 2007 Jul;9(4):540-7.

PMID:
17587396
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk